Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family (Hsp40) member B1 (DNAJB1) is a molecular chaperone belonging to the DnaJ/Hsp40 family, characterized by a conserved J-domain and primarily functioning to regulate the activity of Hsp70 heat shock proteins. DNAJB1 assists in protein folding, prevents aggregation of misfolded proteins, and is critical in cellular stress responses by stimulating the ATPase activity of Hsp70 chaperones. DNAJB1 interacts with several partners, including HSP70, HSPA4, and STUB1, and plays a role in a wide range of cellular processes involving protein quality control. The DNAJB1-PRKACA gene fusion product acts as a potent oncogenic driver specific to fibrolamellar carcinoma, making it an important diagnostic and therapeutic biomarker for this cancer subtype.
Not applicable for direct drug targeting; its disease involvement is typically via chaperone function modulation or oncogenic fusion (as in DNAJB1-PRKACA)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family (Hsp40) member B1 (DNAJB1).